Birth Control Patch Facts, Info, FAQ, Forum

Are there any risks associated with using ORTHO EVRA?

Filed under: — admin @ 11:28 pm

Join the class action lawsuit against the birth control patch made by Ortho-McNeil and get big $$$ from their deep pockets ;)

The contraceptive patch contains hormones similar to those in birth control pills. Hormonal contraceptives are not for everybody. Most side effects of the contraceptive patch are not serious and those that are, occur infrequently. Serious risks, which can be life threatening, include blood clots, stroke or heart attacks and are increased if you smoke cigarettes. Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you are over 35.

Women who use hormonal contraceptives are strongly advised not to smoke. Some women should not use the contraceptive patch, including women who have blood clots, certain cancers, a history of heart attack or stroke, as well as those who are or may be pregnant. The contraceptive patch does not protect against HIV or other sexually transmitted diseases.


Tell a friend about "The Birth Control Patch"
Social Bookmarks: add to any service! Socializer blinklist blogmarks buddymarks delicious digg feedmarker furl google Lookmarks Jookster ma.gnolia netvouz newsvine onlywire reddit rawsugar Mojo this page at Rojo scuttle shadows simpy smarking spurl Technorati unalog wink yahoo

next post: Are there any side effects associated with ORTHO EVRA?


Latest Birth Control Patch News



Ever since a 22-year-old Carmichael mother crumpled in her driveway and died, her family has been wondering: Did Katie Payne's choice of birth control kill her? Anthony Greenfield cuddles his 11-month-old son, Peyton, during a feeding Wednesday. Greenfield's fiancée, Katie Payne, 22, died of a blood clot in her lung Aug. 13 after a trip to the gym. Belinda Payne shows grandson ...

Latest News as of: Mon, 01 Sep 2008 07:12:51 GMT

Agile Therapeutics, Inc., announced that it successfully completed two key clinical trials in the development of the company's new, innovative low-dose, once-weekly, contraceptive patch, which the company refers to by its internal product code AG-200-15. The Phase 2b safety and efficacy study successfully met its primary endpoint of ovulation suppression, cycle control and safety.

Latest News as of: Thu, 04 Sep 2008 14:12:00 GMT